Clinical Trial Update: Reflux Esophagitis Phase III Study (Maintenance Treatment) [Phase 3]

View source ↗

Summary

A Phase III maintenance-treatment trial for reflux esophagitis sponsored by AstraZeneca has completed, with results posted in June 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reflux Esophagitis

Snippet

Sponsor: AstraZeneca | Conditions: Reflux Esophagitis | Phase 3 | Status: COMPLETED | Results posted: 2010-06-17